| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2142803 | Lung Cancer | 2010 | 6 Pages |
Abstract
Type of surgical resection was the major factor influencing outcome in patients with stage IIIA (N2) NSCLC after induction chemotherapy. These results suggest that patients with stage IIIA (N2) NSCLC may benefit from surgical resection, as long as a lobectomy can be performed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ingrid Kappers, Johanna W. van Sandick, Sjaak A. Burgers, José S.A. Belderbos, Nico van Zandwijk, Houke M. Klomp,